If you have been reading about copper(II) complex and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2025-12-21. Where a claim depends on a specific study, the study is described rather than over-claimed.
The peptide was first isolated from human albumin in 1973 by Loren Pickart, who later described its copper-binding behavior. Early work linked the complex to wound healing and tissue remodeling. Plasma levels of GHK decline with age, a pattern that stimulated interest in topical and supplemental applications. Researchers have reported that the tripeptide influences collagen synthesis, antioxidant defense, and inflammatory signaling in cell and animal models. Human clinical evidence remains limited and often relies on small studies.
Commercial products list GHK-Cu as copper tripeptide-1, a cosmetic ingredient. Formulators value its blue color and water solubility, which allow incorporation into serums, creams, and masks. Regulatory treatment varies: in the United States it appears in cosmetics, while some jurisdictions classify certain claims as drug-like. The compound is not an approved drug for any indication. Studies continue to examine its effects on skin, hair, and wound repair, but dosage, delivery, and long-term safety questions remain open.
Several names circulate for the same material, which complicates literature searches. Cosmetic ingredient lists often use copper tripeptide-1, while older biochemistry papers use glycyl-L-histidyl-lysine or its abbreviation GHK. The copper complex is sometimes written as GHK-Cu(II) to make the oxidation state explicit. Terminology is not fully standardized, so matching a compound across sources requires attention to the exact sequence, the counterion, and the stated copper content. Reviews that compare studies must account for these naming differences before drawing conclusions.
GHK-Cu is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine, a short sequence of three amino acids. The peptide was first isolated from human plasma in 1973 during research on factors that influence tissue repair in liver. Its ability to bind copper ions became a central point of interest because the metal changes the peptide's chemistry and its behaviour in laboratory systems. Today the compound appears in cosmetic formulations, cell-culture studies, and biochemistry literature under several names.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Copper(II) tripeptide complex | Contains glycyl-histidyl-lysine ligand |
| Peptide sequence | Gly-His-Lys | N-terminal glycine, C-terminal lysine |
| Molecular formula | C14H22CuN6O4 | Commonly cited for the 1:1 complex |
| Appearance | Blue to blue-violet solid | Color arises from copper d-d transitions |
| Solubility | Water-soluble | Also dissolves in some polar solvents |
Research interest in GHK-Cu centers on its ability to deliver copper and to influence cellular processes in laboratory models. In cell culture and animal studies, the complex has been linked to collagen synthesis, antioxidant enzyme activity, and expression of genes associated with tissue remodeling. These effects are not equivalent to proven clinical outcomes. The mechanisms proposed include copper transfer to cuproenzymes, modulation of growth factor signaling, and interactions with extracellular matrix components. How much of the observed activity depends on intact GHK-Cu versus free copper or free peptide is not fully resolved.
The compound entered scientific literature in the 1970s, when plasma factors with copper-binding activity were isolated and characterized. Later work expanded into wound healing, skin biology, and cosmetic formulation, where copper tripeptide-1 became a recognized ingredient name. Most published studies remain preclinical or small-scale, and findings are often reported in specialized dermatology or peptide journals. Regulatory treatment varies: some jurisdictions allow it as a cosmetic ingredient, while research-grade material is sold for laboratory use. Questions about optimal delivery, target tissues, and long-term effects continue to be investigated rather than settled.
GHK-Cu is a coordination complex formed between the tripeptide glycyl-L-histidyl-L-lysine and a copper(II) ion. The peptide binds copper through its histidine imidazole nitrogen, its terminal amino group, and a deprotonated amide nitrogen, creating a stable chelate ring. The resulting complex carries a distinctive blue to blue-violet color, which arises from copper d-d electronic transitions. In the solid state it is usually handled as a powder, while in solution the complex can dissociate and re-form depending on pH and competing ligands. The name copper tripeptide-1 is widely used in ingredient listings.
The tripeptide was first isolated from a human plasma filtrate in 1973 during studies of tissue repair factors. Later work detected the free peptide and its copper complex in saliva, urine, and wound fluid, suggesting a natural role in tissue remodeling. Plasma concentrations reported in early literature decline with age, a pattern often cited in discussions of skin aging. Whether these endogenous levels are directly functional or largely incidental remains an open question. The peptide sequence is conserved across mammalian species.
The compound was first isolated from human plasma by the biochemist Loren Pickart in 1973. Early work identified it as a factor that altered the behavior of cultured liver cells, and later studies linked it to connective tissue and wound-related processes. Reported plasma concentrations fall markedly between roughly age twenty and age sixty, a pattern that generated interest in copper peptide biology. Whether that decline has functional consequences remains an open question, because differences observed across age groups do not by themselves establish causation. Research interest later expanded into cosmetic and tissue-culture settings.
Mechanistic accounts focus on how the complex delivers copper and how the released peptide interacts with the extracellular matrix. Copper is an essential cofactor for lysyl oxidase and other enzymes involved in collagen and elastin cross-linking, and GHK is one of several peptides able to carry the metal. Reported effects include altered gene expression in fibroblasts and changes in matrix metalloproteinase activity, although many of these findings come from cell culture rather than whole organisms. The relative contribution of the peptide backbone, the copper ion, and downstream copper metabolism is not fully resolved.
GHK-Cu is a coordination complex formed between the tripeptide glycyl-L-histidyl-lysine and a copper(II) ion. The peptide sequence is conventionally written as Gly-His-Lys, abbreviated GHK. Copper binds through the imidazole nitrogen of histidine, the alpha-amino group, and a deprotonated amide nitrogen, producing a square-planar geometry. The complex carries a net positive charge near physiological pH and is intensely blue in aqueous solution. The metal-free peptide is often written simply as GHK, while the copper-bound form is written GHK-Cu.
=== Ma–Me === Alan MacDiarmid (1927–2007), American-New Zealand chemist who discovered conductive polymers, 2000 Nobel Prize in Chemistry Carolina Henriette Mac Gillavry (1904–1993), Dutch chemist and crystallographer known for discoveries on the use of diffraction in crystallography Roderick MacKinnon (born 1956), American biophsicist known for work on ion channels; 2003 Nobel Prize in Chemistry Pierre Macquer (1718–1784), French chemist known for Dictionnaire de chymie Rudolph A. Marcus (1923–2026), Canadian chemist known for work on the theory of electron transfer reactions; 1992 Nobel Prize in Chemistry Jacob A. Marinsky (1918–2005), American chemist, co-discovered the element promethium Jean Charles Galissard de Marignac (1817–1894), Swiss chemist who discovered ytterbium and co-discovered gadolinium Vladimir Vasilevich Markovnikov (1838–1904), Russian chemist known for Markovnikov's rule describing addition reactions of hydrogen halides and alkenes Tobin J. Marks (born 1944), American inorganic chemist and materials scientist known for work in polymerization catalysts Alan G.
Different cell types within adipose tissue exhibit distinct DNA methylation patterns. Mature adipocytes and adipose progenitor cells (ASPCs) show a high degree of hypomethylation, affecting more than 50% of their regulatory regions. This hypomethylation is associated with the activation of genes involved in triglyceride synthesis, such as glycerol‑3‑phosphate acyltransferase 1 (GPAM). In contrast, myeloid cells display approximately 73% hypermethylated regions, reflecting an epigenetic program opposite to that of the adipocytic lineage. Overall, there is a direct relationship between DNA demethylation and gene expression, whereby highly expressed genes tend to exhibit low methylation levels. These epigenetic patterns contribute to defining the functional identity of the different cell types within subcutaneous adipose tissue (SAT).
== Clinical Significance == In diseases related to the cartilage, the territorial matrix undergoes structural and material changes, leading to degradation of the joints, like in the case of osteoarthritis. Osteoarthritis occurs when the proteoglycans and collagen fibers degrade and become disorganized. Consequently, the decreased mechanical support makes chondrocytes more vulnerable to damage. Matrix-degrading enzymes including matrix metalloproteinases (MMPs) target the region which can accelerate cartilage degradation. Attempts to restore a functional territorial matrix is a particular area of interest in tissue engineering and cartilage repair, since its structure significantly contributes to optimal mechanical and biochemical behavior. Studies on biomimetic proteoglycans, which mimic the natural existing component of the ECM, and their effect on neighboring cartilage regions have shown promising results for strengthening cartilage with osteoarthritis. Additionally, biomaterials designed to mimic native composition and mechanical properties of cartilage, especially those with synthetic proteoglycans or collagen, have shown experimental promise. In combination with these structures, the durability of engineering cartilage may be enhanced by regenerating the territorial matrix and could improve integration with native tissue.
The speaker of the Riksdag nominates a prime minister (Swedish: statsminister, literally minister of state) after holding talks with leaders of the various party groups in the Riksdag. The nomination is then put to a vote. The nomination is rejected (meaning the speaker must find a new nominee) only if an absolute majority of the members (175 members) vote "no"; otherwise, it is confirmed. This means the Riksdag can consent to a prime minister without casting any "yes" votes. After being elected the prime minister appoints the cabinet ministers and announces them to the Riksdag. The new Government takes office at a special council held at the Royal Palace before the monarch, at which the speaker of the Riksdag formally announces to the monarch that the Riksdag has elected a new prime minister and that the prime minister has chosen his cabinet ministers. The Riksdag can cast a vote of no confidence against any single cabinet minister (Swedish: statsråd), thus forcing a resignation. To succeed, a vote of no confidence must be supported by an absolute majority (175 members) or it has failed. If a vote of no confidence is cast against the prime minister this means the entire government is rejected. A losing government has one week to call for a general election or else the procedure of nominating a new prime minister starts anew.
The term "herbal medicine" is somewhat misleading in that, while plant elements are by far the most commonly used substances in TCM, other, non-botanic substances are used as well: animal, human, fungi, and mineral products are also used. Thus, the term "medicinal" (instead of herb) may be used. A 2019 review of traditional herbal treatments found they are widely used but lacking in scientific evidence, and urged a more rigorous approach by which genuinely useful medicinals might be identified.
Sources: en.wikipedia.org
The reign of Justinian I was a high point in east Roman history. Following his accession in 527, the legal code was rewritten as the Corpus Juris Civilis, which streamlined Roman law across the empire; he reasserted imperial control over religion and morality through purges of pagans, heretics, and other "deviants"; and having ruthlessly subdued the 532 Nika revolt he rebuilt much of Constantinople, including the Hagia Sophia. Justinian I took advantage of the confusion, following Theoderic the Ostrogoth's death, to attempt the reconquest of Italy. The Vandal Kingdom in North Africa was subjugated in late 533 by the general Belisarius, who then invaded Italy; the Ostrogothic Kingdom mostly ended in 554. In the 540s, Justinian began to suffer reversals on multiple fronts. Capitalising on Constantinople's preoccupation with the West, Khosrow I of the Sasanian Empire invaded Byzantine territory and sacked Antioch in 540. A devastating plague killed a large proportion of the population and severely reduced the empire's social and financial stability. The most difficult period of the Ostrogothic war, against their king Totila, came during this decade; while divisions among Justinian's advisors undercut the administration's response. He also did not fully heal the divisions in Chalcedonian Christianity, as the fifth ecumenical council failed to make a real difference. Justinian died in 565; his reign was more successful than any other emperor, yet he left behind an unstable empire. Justin II (r. 565–578) inherited an empire stretched thin both financially and territorially.
=== Role in cognition === The Thy-1 knockout (KO) mice are viable and appear grossly normal. They display normal social interactions and normal learning in a maze, but fail to learn from social cues (e.g. learning from other mice which foods are safe to eat as compared to wild-type mice). This failure can be rescued by the transgenic expression of Thy-1 or pharmacologic treatment with a GABA (A) receptor antagonists. This suggests that Thy-1 KO mice have excessive GABAergic inhibition in the dentate gyrus and regional inhibition of long-term potentiation.
===== Forms ===== LSD is produced in crystalline form and is then mixed with excipients or redissolved for production in ingestible forms. Liquid solution is either distributed in small vials or, more commonly, sprayed onto or soaked into a distribution medium. Historically, LSD solutions were first sold on sugar cubes, but practical considerations forced a change to tablet form. Appearing in 1968 as an orange tablet measuring about 6 mm across, "Orange Sunshine" acid was the first largely available form of LSD after its possession was made illegal. Tim Scully, a prominent chemist, made some of these tablets, but said that most "Sunshine" in the USA came by way of Ronald Stark, who imported approximately thirty-five million doses from Europe. Over some time, tablet dimensions, weight, shape and concentration of LSD evolved from large (4.5–8.1 mm diameter), heavyweight (≥150 μg), round, high concentration (90–350 μg/tab) dose units to small (2.0–3.5 mm diameter) lightweight (as low as 4.7 μg/tab), variously shaped, lower concentration (12–85 μg/tab, average range 30–40 μg/tab) dose units. LSD tablet shapes have included cylinders, cones, stars, spacecraft, and heart shapes. The smallest tablets became known as "Microdots". After tablets came "computer acid" or "blotter paper LSD", typically made by dipping a preprinted sheet of blotting paper into an LSD/water/alcohol solution. More than 200 types of LSD tablets have been encountered since 1969, and more than 350 blotter paper designs have been observed since 1975.
=== Sports and entertainment === Jack Kramer, 1939: tennis player in International Tennis Hall of Fame Tom Tellez, 1951: former track coach at the University of Houston Darlene Hard, 1954: tennis player in International Tennis Hall of Fame Ivan Guevara, 1955: former college basketball coach at Whittier College and San Jose State University Barney Rosenzweig, 1955: television producer Jerry Pimm, 1956: former basketball coach at University of Utah Bobby Knoop, 1956: retired MLB second baseman for California Angels, Chicago White Sox, and Kansas City Royals Edward James Olmos, 1964: actor and director John Madrid, 1966: jazz and pop music trumpeter
Sources: en.wikipedia.org
GHK is the free tripeptide, while GHK-Cu includes a bound copper(II) ion. The copper complex is the form most often studied for skin and wound-related activity. The two names are sometimes used interchangeably in product labeling, but they refer to distinct chemical species.
Yes, it is found in human plasma, saliva, and urine. Its concentration in plasma tends to decrease with age. This natural presence is one reason researchers have investigated its role in tissue maintenance.
No, GHK-Cu is not an approved drug in major markets. It is widely used as a cosmetic ingredient, where it is listed under names such as copper tripeptide-1. Any therapeutic claims would require separate regulatory review.
The peptide is glycyl-L-histidyl-L-lysine, a three-amino-acid sequence commonly abbreviated GHK. It binds a single copper(II) ion under typical laboratory conditions. The free peptide and the copper complex are separate chemical species with different properties.